메뉴 건너뛰기




Volumn 588, Issue 5, 2014, Pages 653-658

Targeting of the MET receptor tyrosine kinase by small molecule inhibitors leads to MET accumulation by impairing the receptor downregulation

Author keywords

CBL; MET; MET Tyr1003; Receptor downregulation; Receptor ubiquitination; Small molecule tyrosine kinase inhibitor

Indexed keywords

5 (2,6 DICHLOROBENZYLSULFONYL) 3 [3,5 DIMETHYL 4 [2 (1 PYRROLIDINYLMETHYL) 1 PYRROLIDINYLCARBONYL] 1H PYRROL 2 YLMETHYLENE] 1,3 DIHYDRO 2H INDOL 2 ONE; CBL PROTEIN; CRIZOTINIB; EMD 1214063; MET RECEPTOR TYROSINE KINASE; N (3 CHLOROPHENYL) 3 [3,5 DIMETHYL 4 (4 METHYL 1 PIPERAZINYLCARBONYL) 1H PYRROL 2 YLMETHYLENE] 2,3 DIHYDRO N METHYL 2 OXO 1H INDOLE 5 SULFONAMIDE; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; SCATTER FACTOR RECEPTOR; UNCLASSIFIED DRUG;

EID: 84896715095     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2013.12.025     Document Type: Article
Times cited : (24)

References (32)
  • 1
    • 0030799090 scopus 로고    scopus 로고
    • Activating mutations for the met tyrosine kinase receptor in human cancer
    • [Research Support, U.S. Gov't, P.H.S.]
    • M. Jeffers, L. Schmidt, N. Nakaigawa, C.P. Webb, G. Weirich, and T. Kishida et al. Activating mutations for the met tyrosine kinase receptor in human cancer Proc. Natl. Acad. Sci. U.S.A. 94 Oct 14, 21 1997 11445 11450 [Research Support, U.S. Gov't, P.H.S.]
    • (1997) Proc. Natl. Acad. Sci. U.S.A. , vol.94 , Issue.OCT 14 21 , pp. 11445-11450
    • Jeffers, M.1    Schmidt, L.2    Nakaigawa, N.3    Webb, C.P.4    Weirich, G.5    Kishida, T.6
  • 2
    • 17344381429 scopus 로고    scopus 로고
    • Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas
    • [Research Support, Non-U.S. Gov't]
    • L. Schmidt, F.M. Duh, F. Chen, T. Kishida, G. Glenn, and P. Choyke et al. Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas Nat. Genet. 16 May, 1 1997 68 73 [Research Support, Non-U.S. Gov't]
    • (1997) Nat. Genet. , vol.16 , Issue.MAY 1 , pp. 68-73
    • Schmidt, L.1    Duh, F.M.2    Chen, F.3    Kishida, T.4    Glenn, G.5    Choyke, P.6
  • 3
    • 33847260150 scopus 로고    scopus 로고
    • Tyrosine kinase mutations in human cancer
    • E. Lengyel, K. Sawada, and R. Salgia Tyrosine kinase mutations in human cancer Curr Mol Med. 7 1 2007 77 84
    • (2007) Curr Mol Med. , vol.7 , Issue.1 , pp. 77-84
    • Lengyel, E.1    Sawada, K.2    Salgia, R.3
  • 4
    • 0029809118 scopus 로고    scopus 로고
    • Branching tubulogenesis but not scatter of madin-darby canine kidney cells requires a functional Grb2 binding site in the Met receptor tyrosine kinase
    • [Research Support, Non-U.S. Gov't]
    • T.M. Fournier, D. Kamikura, K. Teng, and M. Park Branching tubulogenesis but not scatter of madin-darby canine kidney cells requires a functional Grb2 binding site in the Met receptor tyrosine kinase J. Biol. Chem. 271 Sep 6, 36 1996 22211 22217 [Research Support, Non-U.S. Gov't]
    • (1996) J. Biol. Chem. , vol.271 , Issue.SEP 6 36 , pp. 22211-22217
    • Fournier, T.M.1    Kamikura, D.2    Teng, K.3    Park, M.4
  • 5
    • 0035930341 scopus 로고    scopus 로고
    • Mutation of the c-Cbl TKB domain binding site on the Met receptor tyrosine kinase converts it into a transforming protein
    • [Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.]
    • P. Peschard, T.M. Fournier, L. Lamorte, M.A. Naujokas, H. Band, and W.Y. Langdon et al. Mutation of the c-Cbl TKB domain binding site on the Met receptor tyrosine kinase converts it into a transforming protein Mol. Cell. 8 Nov, 5 2001 995 1004 [Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.]
    • (2001) Mol. Cell. , vol.8 , Issue.NOV 5 , pp. 995-1004
    • Peschard, P.1    Fournier, T.M.2    Lamorte, L.3    Naujokas, M.A.4    Band, H.5    Langdon, W.Y.6
  • 6
    • 0035473477 scopus 로고    scopus 로고
    • Beyond the RING: CBL proteins as multivalent adapters
    • [Research Support, U.S. Gov't, P.H.S. Review]
    • A.Y. Tsygankov, A.M. Teckchandani, E.A. Feshchenko, and G. Swaminathan Beyond the RING: CBL proteins as multivalent adapters Oncogene 20 Oct 1, 44 2001 6382 6402 [Research Support, U.S. Gov't, P.H.S. Review]
    • (2001) Oncogene , vol.20 , Issue.OCT 1 44 , pp. 6382-6402
    • Tsygankov, A.Y.1    Teckchandani, A.M.2    Feshchenko, E.A.3    Swaminathan, G.4
  • 7
    • 27144512084 scopus 로고    scopus 로고
    • Met/Hepatocyte growth factor receptor ubiquitination suppresses transformation and is required for Hrs phosphorylation
    • [Research Support, Non-U.S. Gov't]
    • J.V. Abella, P. Peschard, M.A. Naujokas, T. Lin, C. Saucier, and S. Urbe et al. Met/Hepatocyte growth factor receptor ubiquitination suppresses transformation and is required for Hrs phosphorylation Mol. Cell. Biol. 25 Nov, 21 2005 9632 9645 [Research Support, Non-U.S. Gov't]
    • (2005) Mol. Cell. Biol. , vol.25 , Issue.NOV 21 , pp. 9632-9645
    • Abella, J.V.1    Peschard, P.2    Naujokas, M.A.3    Lin, T.4    Saucier, C.5    Urbe, S.6
  • 8
    • 0035901973 scopus 로고    scopus 로고
    • Down-regulation of MET, the receptor for hepatocyte growth factor
    • [Research Support, Non-U.S. Gov't]
    • D.E. Hammond, S. Urbe, G.F. Vande Woude, and M.J. Clague Down-regulation of MET, the receptor for hepatocyte growth factor Oncogene 20 May 17, 22 2001 2761 2770 [Research Support, Non-U.S. Gov't]
    • (2001) Oncogene , vol.20 , Issue.MAY 17 22 , pp. 2761-2770
    • Hammond, D.E.1    Urbe, S.2    Vande Woude, G.F.3    Clague, M.J.4
  • 9
    • 36049051915 scopus 로고    scopus 로고
    • Oncogenic activation of the Met receptor tyrosine kinase fusion protein, Tpr-Met, involves exclusion from the endocytic degradative pathway
    • [Research Support, Non-U.S. Gov't]
    • H.H. Mak, P. Peschard, T. Lin, M.A. Naujokas, D. Zuo, and M. Park Oncogenic activation of the Met receptor tyrosine kinase fusion protein, Tpr-Met, involves exclusion from the endocytic degradative pathway Oncogene 26 Nov 8, 51 2007 7213 7221 [Research Support, Non-U.S. Gov't]
    • (2007) Oncogene , vol.26 , Issue.NOV 8 51 , pp. 7213-7221
    • Mak, H.H.1    Peschard, P.2    Lin, T.3    Naujokas, M.A.4    Zuo, D.5    Park, M.6
  • 10
    • 61549138135 scopus 로고    scopus 로고
    • Activation of MET by gene amplification or by splice mutations deleting the juxtamembrane domain in primary resected lung cancers
    • [Research Support, Non-U.S. Gov't]
    • R. Onozato, T. Kosaka, H. Kuwano, Y. Sekido, Y. Yatabe, and T. Mitsudomi Activation of MET by gene amplification or by splice mutations deleting the juxtamembrane domain in primary resected lung cancers J. Thorac. Oncol. 4 Jan, 1 2009 5 11 [Research Support, Non-U.S. Gov't]
    • (2009) J. Thorac. Oncol. , vol.4 , Issue.JAN 1 , pp. 5-11
    • Onozato, R.1    Kosaka, T.2    Kuwano, H.3    Sekido, Y.4    Yatabe, Y.5    Mitsudomi, T.6
  • 11
    • 31544462584 scopus 로고    scopus 로고
    • Somatic mutations lead to an oncogenic deletion of met in lung cancer
    • M. Kong-Beltran, S. Seshagiri, J. Zha, W. Zhu, K. Bhawe, and N. Mendoza et al. Somatic mutations lead to an oncogenic deletion of met in lung cancer Cancer Res. 66 Jan 1, 1 2006 283 289
    • (2006) Cancer Res. , vol.66 , Issue.JAN 1 1 , pp. 283-289
    • Kong-Beltran, M.1    Seshagiri, S.2    Zha, J.3    Zhu, W.4    Bhawe, K.5    Mendoza, N.6
  • 12
    • 13944276728 scopus 로고    scopus 로고
    • Functional expression and mutations of c-Met and its therapeutic inhibition with SU11274 and small interfering RNA in non-small cell lung cancer
    • [Research Support, Non-U.S. Gov't]
    • P.C. Ma, R. Jagadeeswaran, S. Jagadeesh, M.S. Tretiakova, V. Nallasura, and E.A. Fox et al. Functional expression and mutations of c-Met and its therapeutic inhibition with SU11274 and small interfering RNA in non-small cell lung cancer Cancer Res. 65 Feb 15, 4 2005 1479 1488 [Research Support, Non-U.S. Gov't]
    • (2005) Cancer Res. , vol.65 , Issue.FEB 15 4 , pp. 1479-1488
    • Ma, P.C.1    Jagadeeswaran, R.2    Jagadeesh, S.3    Tretiakova, M.S.4    Nallasura, V.5    Fox, E.A.6
  • 13
    • 77950859967 scopus 로고    scopus 로고
    • Gastric cancer cell line Hs746T harbors a splice site mutation of c-Met causing juxtamembrane domain deletion
    • Y. Asaoka, M. Tada, T. Ikenoue, M. Seto, M. Imai, and K. Miyabayashi et al. Gastric cancer cell line Hs746T harbors a splice site mutation of c-Met causing juxtamembrane domain deletion Biochem. Biophys. Res. Commun. 394 Apr 16, 4 2010 1042 1046
    • (2010) Biochem. Biophys. Res. Commun. , vol.394 , Issue.APR 16 4 , pp. 1042-1046
    • Asaoka, Y.1    Tada, M.2    Ikenoue, T.3    Seto, M.4    Imai, M.5    Miyabayashi, K.6
  • 15
    • 0029850677 scopus 로고    scopus 로고
    • Rab11 regulates recycling through the pericentriolar recycling endosome
    • [Research Support, Non-U.S. Gov't]
    • O. Ullrich, S. Reinsch, S. Urbe, M. Zerial, and R.G. Parton Rab11 regulates recycling through the pericentriolar recycling endosome J. Cell. Biol. 135 Nov, 4 1996 913 924 [Research Support, Non-U.S. Gov't]
    • (1996) J. Cell. Biol. , vol.135 , Issue.NOV 4 , pp. 913-924
    • Ullrich, O.1    Reinsch, S.2    Urbe, S.3    Zerial, M.4    Parton, R.G.5
  • 16
    • 84896740344 scopus 로고    scopus 로고
    • A Study of Oral PF-02341066, A c-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor
    • NCT00585195. [cited 2013 31.07.2013]
    • A Study Of Oral PF-02341066, A c-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer. NCT00585195. [cited 2013 31.07.2013]; Available from: http://www.clinicaltrials.gov/ct2/show/NCT00585195? term=NCT00585195&rank=1.
    • Patients with Advanced Cancer
  • 18
    • 84858341589 scopus 로고    scopus 로고
    • MET signaling: Novel targeted inhibition and its clinical development in lung cancer
    • [Review]
    • Y. Feng, P.S. Thiagarajan, and P.C. Ma MET signaling: novel targeted inhibition and its clinical development in lung cancer J. Thorac. Oncol. 7 Feb, 2 2012 459 467 [Review]
    • (2012) J. Thorac. Oncol. , vol.7 , Issue.FEB 2 , pp. 459-467
    • Feng, Y.1    Thiagarajan, P.S.2    Ma, P.C.3
  • 19
    • 84856020870 scopus 로고    scopus 로고
    • Targeting c-Met as a promising strategy for the treatment of hepatocellular carcinoma
    • [Research Support, Non-U.S. Gov't Review]
    • J. Gao, Y. Inagaki, P. Song, X. Qu, N. Kokudo, and W. Tang Targeting c-Met as a promising strategy for the treatment of hepatocellular carcinoma Pharmacol. Res. 65 Jan, 1 2012 23 30 [Research Support, Non-U.S. Gov't Review]
    • (2012) Pharmacol. Res. , vol.65 , Issue.JAN 1 , pp. 23-30
    • Gao, J.1    Inagaki, Y.2    Song, P.3    Qu, X.4    Kokudo, N.5    Tang, W.6
  • 20
    • 84856152266 scopus 로고    scopus 로고
    • Targeting MET in cancer: Rationale and progress
    • [Research Support, Non-U.S. Gov't Review]
    • E. Gherardi, W. Birchmeier, C. Birchmeier, and G. Vande Woude Targeting MET in cancer: rationale and progress Nat. Rev. Cancer 12 Feb, 2 2012 89 103 [Research Support, Non-U.S. Gov't Review]
    • (2012) Nat. Rev. Cancer , vol.12 , Issue.FEB 2 , pp. 89-103
    • Gherardi, E.1    Birchmeier, W.2    Birchmeier, C.3    Vande Woude, G.4
  • 21
    • 80051760389 scopus 로고    scopus 로고
    • Development of c-MET pathway inhibitors
    • [Review]
    • X. Liu, R.C. Newton, and P.A. Scherle Development of c-MET pathway inhibitors Expert Opin. Investig. Drugs 20 Sep, 9 2011 1225 1241 [Review]
    • (2011) Expert Opin. Investig. Drugs , vol.20 , Issue.SEP 9 , pp. 1225-1241
    • Liu, X.1    Newton, R.C.2    Scherle, P.A.3
  • 22
    • 3142691273 scopus 로고    scopus 로고
    • The Met kinase inhibitor SU11274 exhibits a selective inhibition pattern toward different receptor mutated variants
    • [Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.]
    • S. Berthou, D.M. Aebersold, L.S. Schmidt, D. Stroka, C. Heigl, and B. Streit et al. The Met kinase inhibitor SU11274 exhibits a selective inhibition pattern toward different receptor mutated variants Oncogene 23 Jul 8, 31 2004 5387 5393 [Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.]
    • (2004) Oncogene , vol.23 , Issue.JUL 8 31 , pp. 5387-5393
    • Berthou, S.1    Aebersold, D.M.2    Schmidt, L.S.3    Stroka, D.4    Heigl, C.5    Streit, B.6
  • 23
    • 76849098324 scopus 로고    scopus 로고
    • Differential inhibition sensitivities of MET mutants to the small molecule inhibitor SU11274
    • [Research Support, Non-U.S. Gov't]
    • Y. Zimmer, A.V. Vaseva, M. Medová, B. Streit, W. Blank-Liss, and R.H. Greiner et al. Differential inhibition sensitivities of MET mutants to the small molecule inhibitor SU11274 Cancer Lett. 289 Mar 28, 2 2010 228 236 [Research Support, Non-U.S. Gov't]
    • (2010) Cancer Lett. , vol.289 , Issue.MAR 28 2 , pp. 228-236
    • Zimmer, Y.1    Vaseva, A.V.2    Medová, M.3    Streit, B.4    Blank-Liss, W.5    Greiner, R.H.6
  • 24
    • 0141481285 scopus 로고    scopus 로고
    • A novel small molecule met inhibitor induces apoptosis in cells transformed by the oncogenic TPR-MET tyrosine kinase
    • [Research Support, Non-U.S. Gov't]
    • M. Sattler, Y.B. Pride, P. Ma, J.L. Gramlich, S.C. Chu, and L.A. Quinnan et al. A novel small molecule met inhibitor induces apoptosis in cells transformed by the oncogenic TPR-MET tyrosine kinase Cancer Res. 63 Sep 1, 17 2003 5462 5469 [Research Support, Non-U.S. Gov't]
    • (2003) Cancer Res. , vol.63 , Issue.SEP 1 17 , pp. 5462-5469
    • Sattler, M.1    Pride, Y.B.2    Ma, P.3    Gramlich, J.L.4    Chu, S.C.5    Quinnan, L.A.6
  • 25
    • 84879001675 scopus 로고    scopus 로고
    • EMD 1214063 and EMD 1204831 constitute a new class of potent and highly selective c-Met inhibitors
    • [Research Support, Non-U.S. Gov't]
    • F. Bladt, B. Faden, M. Friese-Hamim, C. Knuehl, C. Wilm, and C. Fittschen et al. EMD 1214063 and EMD 1204831 constitute a new class of potent and highly selective c-Met inhibitors Clin. Cancer Res. 19 Jun 1, 11 2013 2941 2951 [Research Support, Non-U.S. Gov't]
    • (2013) Clin. Cancer Res. , vol.19 , Issue.JUN 1 11 , pp. 2941-2951
    • Bladt, F.1    Faden, B.2    Friese-Hamim, M.3    Knuehl, C.4    Wilm, C.5    Fittschen, C.6
  • 26
    • 84887499021 scopus 로고    scopus 로고
    • The novel ATP-competitive inhibitor of the MET hepatocyte growth factor receptor EMD1214063 displays inhibitory activity against selected MET-mutated variants
    • M. Medová, B. Pochon, B. Streit, W. Blank-Liss, P. Francica, and D. Stroka et al. The novel ATP-competitive inhibitor of the MET hepatocyte growth factor receptor EMD1214063 displays inhibitory activity against selected MET-mutated variants Mol. Cancer Ther. 12 Nov, 11 2013 2415 2424
    • (2013) Mol. Cancer Ther. , vol.12 , Issue.NOV 11 , pp. 2415-2424
    • Medová, M.1    Pochon, B.2    Streit, B.3    Blank-Liss, W.4    Francica, P.5    Stroka, D.6
  • 27
    • 0030839876 scopus 로고    scopus 로고
    • Efficient cellular transformation by the Met oncoprotein requires a functional Grb2 binding site and correlates with phosphorylation of the Grb2-associated proteins, Cbl and Gab1
    • [Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.]
    • E.D. Fixman, M. Holgado-Madruga, L. Nguyen, D.M. Kamikura, T.M. Fournier, and A.J. Wong et al. Efficient cellular transformation by the Met oncoprotein requires a functional Grb2 binding site and correlates with phosphorylation of the Grb2-associated proteins, Cbl and Gab1 J. Biol. Chem. 272 Aug 8, 32 1997 20167 20172 [Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.]
    • (1997) J. Biol. Chem. , vol.272 , Issue.AUG 8 32 , pp. 20167-20172
    • Fixman, E.D.1    Holgado-Madruga, M.2    Nguyen, L.3    Kamikura, D.M.4    Fournier, T.M.5    Wong, A.J.6
  • 28
    • 0037075606 scopus 로고    scopus 로고
    • The endophilin-CIN85-Cbl complex mediates ligand-dependent downregulation of c-Met
    • [Research Support, Non-U.S. Gov't]
    • A. Petrelli, G.F. Gilestro, S. Lanzardo, P.M. Comoglio, N. Migone, and S. Giordano The endophilin-CIN85-Cbl complex mediates ligand-dependent downregulation of c-Met Nature 416 Mar 14, 6877 2002 187 190 [Research Support, Non-U.S. Gov't]
    • (2002) Nature , vol.416 , Issue.MAR 14 6877 , pp. 187-190
    • Petrelli, A.1    Gilestro, G.F.2    Lanzardo, S.3    Comoglio, P.M.4    Migone, N.5    Giordano, S.6
  • 29
    • 84861733799 scopus 로고    scopus 로고
    • MET: A promising anticancer therapeutic target
    • [Review]
    • S. Peters, and A.A. Adjei MET: a promising anticancer therapeutic target Nat. Rev. Clin. Oncol. 9 Jun, 6 2012 314 326 [Review]
    • (2012) Nat. Rev. Clin. Oncol. , vol.9 , Issue.JUN 6 , pp. 314-326
    • Peters, S.1    Adjei, A.A.2
  • 31
    • 84891319812 scopus 로고    scopus 로고
    • The Molecular crosstalk between the MET receptor tyrosine kinase and the DNA damage response-biological and clinical aspects
    • Dec (19, 1)
    • M. Medová, D.M. Aebersold, and Y. Zimmer The Molecular crosstalk between the MET receptor tyrosine kinase and the DNA damage response-biological and clinical aspects Cancers (Basel) 6 2013 1 27 Dec (19, 1)
    • (2013) Cancers (Basel) , vol.6 , pp. 1-27
    • Medová, M.1    Aebersold, D.M.2    Zimmer, Y.3
  • 32
    • 0033392493 scopus 로고    scopus 로고
    • Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1
    • [Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.]
    • G. Levkowitz, H. Waterman, S.A. Ettenberg, M. Katz, A.Y. Tsygankov, and I. Alroy et al. Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1 Mol. Cell. 4 Dec, 6 1999 1029 1040 [Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.]
    • (1999) Mol. Cell. , vol.4 , Issue.DEC. 6 , pp. 1029-1040
    • Levkowitz, G.1    Waterman, H.2    Ettenberg, S.A.3    Katz, M.4    Tsygankov, A.Y.5    Alroy, I.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.